Closed
The Marked Chart Wire · Business
Eli Lilly
Eli Lilly is set to report third-quarter results, with analysts expecting revenue to exceed forecasts due to resilient demand for Zepbound and Mounjaro.
Part of a series: Eli Lilly shares rise ahead of third-quarter earnings
Prices from Before the open · based on Wed close · Opens 9:30 AM ET. Each tile opens the stock's chart and news.
New to this? Read: Reading a stock chart
Eli Lilly
Eli Lilly is scheduled to release its third-quarter financial results, with performance expected to be driven by its obesity and diabetes medications.
HotAlphabet
Investors reacted negatively to Alphabet's quarterly results, which showed revenue below expectations. The miss is viewed as an early indicator that artificial intelligence is reducing demand for traditional search services.
BorgWarner
BorgWarner reported GAAP earnings per share of $1.08, missing the consensus by $0.13. The company's revenue came in at $3.49 billion, matching analyst forecasts.
Haleon
Haleon's chief executive stated that 70 percent of the company's cold and flu revenue comes from outside the United States. International season start has not yet been observed, while current sales are slightly down.
Shell Earnings
Shell reported third-quarter adjusted earnings per share of $3.86, exceeding the $3.65 consensus. Sales came in at $92.848 billion, missing the $99.725 billion forecast.
Linde
Linde increased its fiscal year profit forecast following third-quarter results that exceeded market expectations.
Fast headlines, summarized. Not verified and not advice. Check the full story before you act.